Update on Biosimilar Launches and Development

Published date30 March 2018
Law FirmGoodwin
Subject MatterEU,Biosimilars,Pharmaceutical Industry,European Medicines Agency (EMA),Marketing Authorization Application,Biocon,Therapeutic Goods Act

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT